Targeted siRNA Delivery by Bioinspired Cancer Cell Membrane-Coated Nanoparticles with Enhanced Anti-Cancer Immunity

References

• Suresh Kumar N, Padma Suvarna R, Chandra Babu Naidu K, Banerjee P, Ratnamala A, Manjunatha H. A review on biological and biomimetic materials and their applications. Applied Physics A. 2020;126(6):445. doi:10.1007/s00339-020-03633-z
   Web of Science ®Google Scholar
• Kim K, Ryu JH, Koh M-Y, et al. Coagulopathy-independent, bioinspired hemostatic materials: a full research story from preclinical models to a human clinical trial. Sci Adva. 2021;7(13):eabc9992. doi:10.1126/sciadv.abc9992
   PubMed Web of Science ®Google Scholar
• Rajabi-Zeleti S, Jalili-Firoozinezhad S, Azarnia M, et al. The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds. Biomaterials. 2014;35(3):970–982. doi:10.1016/j.biomaterials.2013.10.045
   PubMed Web of Science ®Google Scholar
• Fan L, Liu C, Chen X, et al. Directing induced pluripotent stem cell derived neural stem cell fate with a three-dimensional biomimetic hydrogel for spinal cord injury repair. ACS Appl Mater Interfaces. 2018;10(21):17742–17755. doi:10.1021/acsami.8b05293
   PubMed Web of Science ®Google Scholar
• Chen L, Hong W, Ren W, Xu T, Qian Z, He Z. Recent progress in targeted delivery vectors based on biomimetic nanoparticles. Signal Transduct Target Therap. 2021;6(1):225. doi:10.1038/s41392-021-00631-2
   PubMed Web of Science ®Google Scholar
• Chi Y, Yin X, Sun K, et al. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. J Cont Rel. 2017;261:113–125. doi:10.1016/j.jconrel.2017.06.027
   PubMed Web of Science ®Google Scholar
• Li L, Zhang R, Gu W, Xu ZP. Mannose-conjugated layered double hydroxide nanocomposite for targeted siRNA delivery to enhance cancer therapy. Nanomedicine. 2018;14(7):2355–2364. doi:10.1016/j.nano.2017.06.006
   PubMed Web of Science ®Google Scholar
• Pitchaimani A, Nguyen TDT, Aryal S. Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy. Biomaterials. 2018;160:124–137. doi:10.1016/j.biomaterials.2018.01.018
   PubMed Web of Science ®Google Scholar
• Liu G, Zhao X, Zhang Y, et al. Engineering biomimetic platesomes for pH-responsive drug delivery and enhanced antitumor activity. Adva Mat. 2019;31(32):e1900795. doi:10.1002/adma.201900795
   PubMed Web of Science ®Google Scholar
• Cully M. Exosome-based candidates move into the clinic. Nat Rev Drug Discov. 2021;20(1):6–7. doi:10.1038/d41573-020-00220-y
   PubMed Web of Science ®Google Scholar
• Lombard J. Once upon a time the cell membranes: 175 years of cell boundary research. Biol Direct. 2014;9:32. doi:10.1186/s13062-014-0032-7
   PubMed Web of Science ®Google Scholar
• Papa S, Ferrari R, De Paola M, et al. Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury. J Cont Rel. 2014;174:15–26. doi:10.1016/j.jconrel.2013.11.001
   PubMed Web of Science ®Google Scholar
• Tang W, Yang Y, Yang L, Tang M, Chen Y, Li C. Macrophage membrane-mediated targeted drug delivery for treatment of spinal cord injury regardless of the macrophage polarization states. Asian J Pharm Sci. 2021;16(4):459–470. doi:10.1016/j.ajps.2021.03.005
   PubMed Web of Science ®Google Scholar
• Yu Q, Jiang X, Liu X, et al. Glutathione-modified macrophage-derived cell membranes encapsulated metformin nanogels for the treatment of spinal cord injury. Biomat Adva. 2022;133:112668. doi:10.1016/j.msec.2022.112668
   PubMedGoogle Scholar
• Pei Q, Hu X, Zheng X, et al. Light-activatable red blood cell membrane-camouflaged dimeric prodrug nanoparticles for synergistic photodynamic/chemotherapy. ACS Nano. 2018;12(2):1630–1641. doi:10.1021/acsnano.7b08219
   PubMed Web of Science ®Google Scholar
• Sahoo K, Karumuri S, Hikkaduwa Koralege RS, et al. Molecular and biocompatibility characterization of red blood cell membrane targeted and cell-penetrating-peptide-modified polymeric nanoparticles. Mol Pharm. 2017;14(7):2224–2235. doi:10.1021/acs.molpharmaceut.7b00053
   PubMedGoogle Scholar
• Wang B, Yang P, Ding Y, Qi H, Gao Q, Zhang C. Improvement of the biocompatibility and potential stability of chronically implanted electrodes incorporating coating cell membranes. ACS Appl Mater Interfaces. 2019;11(9):8807–8817. doi:10.1021/acsami.8b20542
   PubMed Web of Science ®Google Scholar
• Ke Y, Zhu J, Chu Y, et al. Bifunctional fusion membrane-based hydrogel enhances antitumor potency of autologous cancer vaccines by activating dendritic cells. Adv Funct Mater. 2022;2201306. doi:10.1002/adfm.202201306
   Web of Science ®Google Scholar
• Liu W-L, Zou M-Z, Liu T, et al. Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells. Nat Commun. 2019;10(1):3199. doi:10.1038/s41467-019-11157-1
   PubMed Web of Science ®Google Scholar
• Liu R, Luo C, Pang Z, et al. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chin Chem Letters. 2023;34(2):107518. doi:10.1016/j.cclet.2022.05.032
   Web of Science ®Google Scholar
• Kubiatowicz LJ, Mohapatra A, Krishnan N, Fang RH, Zhang L. mRNA nanomedicine: design and recent applications. Exploration. 2022;2(6):20210217. doi:10.1002/EXP.20210217
   Google Scholar
• Huang Z, Liu S, Lu N, et al. Nucleus-specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy. Exploration. 2022;2(5):20220013. doi:10.1002/EXP.20220013
   Google Scholar
• Xin Y, Huang M, Guo WW, Huang Q, Zhang LZ, Jiang G. Nano-based delivery of RNAi in cancer therapy. Mol Cancer. 2017;16(1):134. doi:10.1186/s12943-017-0683-y
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Raychaudhuri B, Haqqi T, et al. Stat3 activation is required for the growth of U87 cell-derived tumours in mice. Eur J Cancer. 2009;45(4):677–684. doi:10.1016/j.ejca.2008.11.027
   PubMed Web of Science ®Google Scholar
• Wang X, Wang N, Yang Y, et al. Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy. Biomat Sci. 2019;7(7):3062–3075. doi:10.1039/C9BM00010K
   PubMed Web of Science ®Google Scholar
• Benencia F, Sprague L, McGinty J, Pate M, Muccioli M. Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination. J Biomed Biotechnol. 2012;2012:425476. doi:10.1155/2012/425476
   PubMed Web of Science ®Google Scholar
• Drozina G, Kohoutek J, Jabrane-Ferrat N, Peterlin BM. Expression of MHC II Genes. In: Singh H, Grosschedl R, editors. Molecular Analysis of B Lymphocyte Development and Activation. Berlin, Heidelberg: Springer Berlin Heidelberg; 2005:147–170.
   Google Scholar
• Binnewies M, Mujal AM, Pollack JL, et al. Unleashing type-2 dendritic cells to drive protective antitumor CD4(+) T cell immunity. Cell. 2019;177(3):556–571.e16. doi:10.1016/j.cell.2019.02.005
   PubMed Web of Science ®Google Scholar
• Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503–510. doi:10.1038/ni1582
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411(6836):494–498. doi:10.1038/35078107
   PubMed Web of Science ®Google Scholar
• Ozpolat B, Sood AK, Lopez-Berestein G. Liposomal siRNA nanocarriers for cancer therapy. Adv Drug Deliv Rev. 2014;66:110–116. doi:10.1016/j.addr.2013.12.008
   PubMed Web of Science ®Google Scholar
• Sun T, Wang Y, Wang Y, et al. Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies. Adv Healthcare Mater. 2014;3(8):1283–1291. doi:10.1002/adhm.201400026
   Web of Science ®Google Scholar
• Soe ZC, Thapa RK, Ou W, et al. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy. Colloids Surf B Biointerfaces. 2018;170:718–728. doi:10.1016/j.colsurfb.2018.07.013
   PubMed Web of Science ®Google Scholar
• Patil Y, Shmeeda H, Amitay Y, Ohana P, Kumar S, Gabizon A. Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA). Nanomedicine. 2018;14(4):1407–1416. doi:10.1016/j.nano.2018.04.011
   PubMed Web of Science ®Google Scholar
• Kim I-Y, Kang Y-S, Lee DS, et al. Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. J Cont Rel. 2009;140(1):55–60. doi:10.1016/j.jconrel.2009.07.005
   PubMed Web of Science ®Google Scholar
• Kirpotin DB, Drummond DC, Shao Y, et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 2006;66(13):6732–6740. doi:10.1158/0008-5472.CAN-05-4199
   PubMed Web of Science ®Google Scholar
• Pan W-L, Tan Y, Meng W, et al. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework. Biomaterials. 2022;283:121449. doi:10.1016/j.biomaterials.2022.121449
   PubMed Web of Science ®Google Scholar
• He H, Guo C, Wang J, et al. Leutusome: a biomimetic nanoplatform integrating plasma membrane components of leukocytes and tumor cells for remarkably enhanced solid tumor homing. Nano Lett. 2018;18(10):6164–6174. doi:10.1021/acs.nanolett.8b01892
   PubMed Web of Science ®Google Scholar
• Ye H, Wang K, Lu Q, et al. Nanosponges of circulating tumor-derived exosomes for breast cancer metastasis inhibition. Biomaterials. 2020;242:119932. doi:10.1016/j.biomaterials.2020.119932
   PubMed Web of Science ®Google Scholar
• Sun H, Su J, Meng Q, et al. Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors. Adv Mater. 2016;28(43):9581–9588. doi:10.1002/adma.201602173
   PubMed Web of Science ®Google Scholar
• Xuan M, Shao J, Dai L, He Q, Li J. Macrophage cell membrane camouflaged mesoporous silica nanocapsules for in vivo cancer therapy. Adv Healthcare Mater. 2015;4(11):1645–1652. doi:10.1002/adhm.201500129
   Web of Science ®Google Scholar
• Parodi A, Quattrocchi N, van de Ven AL, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol. 2013;8(1):61–68. doi:10.1038/nnano.2012.212
   PubMed Web of Science ®Google Scholar
• Kang T, Zhu Q, Wei D, et al. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano. 2017;11(2):1397–1411. doi:10.1021/acsnano.6b06477
   PubMed Web of Science ®Google Scholar
• Li J, Ai Y, Wang L, et al. Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. Biomaterials. 2016;76:52–65. doi:10.1016/j.biomaterials.2015.10.046
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Jurado‐Sánchez B, Lin X, Wu Z, He Q. Stem cell membrane‐coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small. 2016;12(30):4056–4062. doi:10.1002/smll.201600624
   PubMed Web of Science ®Google Scholar
• Wang D, Dong H, Li M, et al. Erythrocyte–cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma. ACS nano. 2018;12(6):5241–5252. doi:10.1021/acsnano.7b08355
   PubMed Web of Science ®Google Scholar
• Hu Q, Sun W, Qian C, Wang C, Bomba HN, Gu Z. Anticancer platelet‐mimicking nanovehicles. Adv Mater. 2015;27(44):7043–7050. doi:10.1002/adma.201503323
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhao L, Wang S, et al. Construction of a biomimetic magnetosome and its application as a SiRNA Carrier for high‐performance anticancer therapy. Adv Funct Mater. 2018;28(1):1703326. doi:10.1002/adfm.201703326
   Web of Science ®Google Scholar
• Wang F, Gao W, Thamphiwatana S, et al. Hydrogel retaining toxin-absorbing nanosponges for local treatment of methicillin-resistant staphylococcus aureus infection. Adva Mat. 2015;27(22):3437–3443. doi:10.1002/adma.201501071
   PubMed Web of Science ®Google Scholar
• Zhang Q, Honko A, Zhou J, et al. Cellular nanosponges inhibit SARS-CoV-2 Infectivity. Nano Letter. 2020;20(7):5570–5574. doi:10.1021/acs.nanolett.0c02278
   PubMed Web of Science ®Google Scholar
• Chai Z, Hu X, Wei X, et al. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Control Release. 2017;264:102–111. doi:10.1016/j.jconrel.2017.08.027
   PubMed Web of Science ®Google Scholar
• Wang D, Liu C, You S, et al. Bacterial vesicle-cancer cell hybrid membrane-coated nanoparticles for tumor specific immune activation and photothermal therapy. ACS Appl Mater Interfaces. 2020;12(37):41138–41147. doi:10.1021/acsami.0c13169
   PubMed Web of Science ®Google Scholar
• Frasch CE, van Alphen L, Holst J, Poolman JT, Rosenqvist E. Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease. In: Pollard AJ, Maiden MCJ, editors. Meningococcal Vaccines: Methods and Protocols. Totowa, NJ: Humana Press; 2001:81–107.
   Google Scholar
• Jiang Y, Krishnan N, Zhou J, et al. Engineered cell‐membrane‐coated nanoparticles directly present tumor antigens to promote anticancer immunity. Adv Mater. 2020;32(30):2001808. doi:10.1002/adma.202001808
   PubMed Web of Science ®Google Scholar